The national medical insurance bureau said that paying for vaccines is by no means a simple medical insurance payment. We must do everything possible to ensure that the medical insurance fund plays its greatest role in safeguarding, and use various methods to introduce prices into a reasonable range by stages. In the long run, free vaccination for all is conducive to the rapid establishment of immune barriers, maintaining normal production and living order and healthy economic and social development, thus further promoting the long-term sustainable operation of medical insurance funds. Medical insurance protects COVID-19 patients.
In the past 22 years, China has innovatively played the role of medical insurance in responding to major public health events, and achieved national guarantee and free treatment for COVID-19 patients.
The accumulated balance of the medical insurance fund exceeded 3 trillion yuan for the first time.
Under the background of complicated international and domestic economic situation, the National Medical Insurance Bureau has taken measures such as centralized procurement of drugs and medical consumables, negotiation of medical insurance drug list access, and reform of payment methods. In 22 years, the current balance of the national basic medical insurance fund was about 2.7 billion yuan, and the accumulated balance exceeded 3 trillion yuan for the first time.
The target population of vaccination will be expanded to the elderly aged 6 and above.
Since the implementation of novel coronavirus vaccine for key population on February 5, 2002, the inoculation amount has exceeded 10000 doses by June 38+10/3. Many places have summarized many beneficial practices in the process of vaccination. Generally speaking, the vaccination work in COVID-19 is stable and orderly.
At present, the key population of vaccination is the high-risk and possibly high-spread population aged 18-59. With the continuous improvement of vaccine clinical research data, the need of prevention and control work and the increase of vaccine supply, China will expand the target population of vaccination to more people, including the elderly aged 6 and above.
Faced with a population of 654.38+04 billion, Ceng Yixin, deputy director of the National Health Planning Commission, once said: The vaccination rate in COVID-19 must reach at least 6% or even 7% before universal protection can be established. This means that there are at least 850 million people who need to be vaccinated, and the cost of vaccines involved may be as high as hundreds of billions of yuan. This is undoubtedly the largest immunization program in the world.
How does the medical insurance fund pay for this large amount of expenses? The National Medical Insurance Bureau did not give a clear answer, only said: "We must do everything possible to ensure that medical insurance funds play the greatest role of protection, make good use of centralized procurement with quantity and other ways, and give full play to the strategic procurement role of medical insurance."
The reporter consulted a number of experts in the field of medical insurance research on this matter and was told: "This matter is too sensitive to express opinions."